Literature DB >> 11549592

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

B Bussolati1, C Dunk, M Grohman, C D Kontos, J Mason, A Ahmed.   

Abstract

The known responses of vascular endothelial growth factor (VEGF) are mediated through VEGF receptor-2 (VEGFR-2/KDR) in endothelial cells. However, it is unknown whether VEGFR-1 (Flt-1) is an inert decoy or a signaling receptor for VEGF during physiological or pathological angiogenesis. Here we report that VEGF-stimulated nitric oxide (NO) release is inhibited by blockade of VEGFR-1 and that VEGFR-1 via NO negatively regulates of VEGFR-2-mediated proliferation and promotes formation of capillary networks in human umbilical vein endothelial cells (HUVECs). Inhibition of VEGFR-1 in a murine Matrigel angiogenesis assay induced large aneurysm-like structures. VEGF-induced capillary growth over 14 days was inhibited by anti-VEGFR-2-blocking antibody as determined by reduced tube length between capillary connections (P < 0.0001) in an in vitro angiogenesis assay. In contrast, loss of VEGFR-1 activity with a neutralizing anti-VEGFR-1 antibody resulted in an increase in the accumulation of endothelial cells (P < 0.0001) and a dramatic decrease in the number of capillary connections that were restored by the addition of NO donor. Porcine aortic endothelial (PAE) cells expressing human VEGFR-1 but not VEGFR-2 plated on growth factor-reduced Matrigel rearranged into tube-like structures that were prevented by anti-VEGFR-1 antibody or a cGMP inhibitor. VEGF stimulated NO release from VEGFR-1- but not VEGFR-2-transfected endothelial cells and placenta growth factor-1 stimulated NO release in HUVECs. Blockade of VEGFR-1 increased VEGF-mediated HUVEC proliferation that was inhibited by NO donors, and potentiated by NO synthase inhibitors. These data indicate that VEGFR-1 is a signaling receptor that promotes endothelial cell differentiation into vascular tubes, in part by limiting VEGFR-2-mediated endothelial cell proliferation via NO, which seems to be a molecular switch for endothelial cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549592      PMCID: PMC1850457          DOI: 10.1016/S0002-9440(10)61775-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor.

Authors:  A Passaniti; R M Taylor; R Pili; Y Guo; P V Long; J A Haney; R R Pauly; D S Grant; G R Martin
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

2.  Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells.

Authors:  N Rahimi; V Dayanir; K Lashkari
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.

Authors:  E L Knight; A J Warner; A Maxwell; S A Prigent
Journal:  Oncogene       Date:  2000-11-09       Impact factor: 9.867

4.  Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.

Authors:  S Hiratsuka; Y Maru; A Okada; M Seiki; T Noda; M Shibuya
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells.

Authors:  C Dunk; A Ahmed
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.

Authors:  S Kanno; N Oda; M Abe; Y Terai; M Ito; K Shitara; K Tabayashi; M Shibuya; Y Sato
Journal:  Oncogene       Date:  2000-04-20       Impact factor: 9.867

7.  The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.

Authors:  K J Kim; B Li; K Houck; J Winer; N Ferrara
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model.

Authors:  M C Kibbey; D S Grant; H K Kleinman
Journal:  J Natl Cancer Inst       Date:  1992-11-04       Impact factor: 13.506

10.  A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.

Authors:  S Hauser; H A Weich
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

View more
  79 in total

1.  The effect of previous weight training and concurrent weight training on endurance for functional electrical stimulation cycle ergometry.

Authors:  Jerrold Scott Petrofsky; Mike Laymon
Journal:  Eur J Appl Physiol       Date:  2003-11-15       Impact factor: 3.078

Review 2.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

3.  Isolation and characterization of ovine luteal pericytes and effects of nitric oxide on pericyte expression of angiogenic factors.

Authors:  Joan D Beckman; Anna T Grazul-Bilska; Mary Lynn Johnson; Lawrence P Reynolds; Dale A Redmer
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

4.  Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.

Authors:  Hugo Caldas; Jason R Fangusaro; Daniel R Boué; Michael P Holloway; Rachel A Altura
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

5.  Type 5 phosphodiesterase expression is a critical determinant of the endothelial cell angiogenic phenotype.

Authors:  Bing Zhu; Li Zhang; Mikhail Alexeyev; Diego F Alvarez; Samuel J Strada; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-21       Impact factor: 5.464

Review 6.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

7.  Nitric oxide synthase and VEGF expression in full-term placentas of obese women.

Authors:  Eleonora Salvolini; Arianna Vignini; Jacopo Sabbatinelli; Guendalina Lucarini; Veronica Pompei; Davide Sartini; Anna Maria Cester; Andrea Ciavattini; Laura Mazzanti; Monica Emanuelli
Journal:  Histochem Cell Biol       Date:  2019-09-24       Impact factor: 4.304

8.  Urgent call for reconsideration of chronic kidney disease.

Authors:  Narisa Futrakul; Prasit Futrakul
Journal:  World J Nephrol       Date:  2012-12-06

9.  Anti-SPARC oligopeptide inhibits laser-induced CNV in mice.

Authors:  Hironori Uehara; Ling Luo; Jacquelyn Simonis; Nirbhai Singh; Ethan Will Taylor; Balamurali K Ambati
Journal:  Vision Res       Date:  2009-12-22       Impact factor: 1.886

Review 10.  Fine-tuning the angiogenic response to vascular endothelial growth factor.

Authors:  James K Liao
Journal:  Circ Res       Date:  2008-08-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.